NANOBOTS FIGHT CANCEROUS CELLS

Summary of NANOBOTS FIGHT CANCEROUS CELLS


Researchers from Canadian universities have developed nanorobotic agents using flagellated bacteria to deliver drugs precisely to hypoxic tumor regions, potentially replacing toxic chemotherapy. These self-propelled agents navigate the bloodstream via magnetic fields and oxygen sensors to target resistant cancer cells in mice.

Parts used in the Nanorobotic Cancer Treatment:

  • Flagellated bacteria
  • Magnetic nanoparticles
  • Drug-containing nanoliposomes
  • Oxygen concentration sensor
  • Computer-controlled magnetic field
  • Particle Swarm Optimization algorithm

Researchers from Polytechnique Montréal, Université de Montréal and McGill University have just achieved a spectacular breakthrough in cancer research. They have developed new nanorobotic agents capable of navigating through the bloodstream to administer a drug with precision.

NANOBOTS FIGHT CANCEROUS CELLS 2

Professor Sylvain Martel is holder of the Canada Research Chair in Medical Nanorobotics and the Director of the nanorobotics laboratory at Polytechnique Montreal, where he studies medical applications of nanotechnology. Martel and his team have demonstrated major progress with a new technology that could revolutionize cancer treatment by using guided micro-transporters to deliver drugs. Thus cancerous cells can be locally targeted and then stop their growth.

NANOBOTS FIGHT CANCEROUS CELLS 2

This breakthrough in cancer-fighting research would ditch chemotherapy for nanorobots that fight cancer inside the human body. This research was published in the prestigious journal Nature Nanotechnology in an article titled “Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions.” The article notes the results of the research done on mice, which were successfully administered nanorobotic agents into colorectal tumours.

“These legions of nanorobotic agents were actually composed of more than 100 million flagellated bacteria — and therefore self-propelled — and loaded with drugs that moved by taking the most direct path between the drug’s injection point and the area of the body to cure,” explains Professor Martel “The drug’s propelling force was enough to travel efficiently and enter deep inside the tumours.”

When they enter a tumour, the nanorobotic agents can detect in a wholly autonomous fashion the oxygen-depleted tumour areas, known as hypoxic zones, and deliver the drug to them. This hypoxic zone is created by the substantial consumption of oxygen by rapidly proliferative tumour cells. Hypoxic zones are known to be resistant to most therapies, including radiotherapy. But gaining access to tumours by taking paths as minute as a red blood cell and crossing complex physiological micro-environments does not come without challenges. So Professor Martel and his team used nanotechnology to do it.

https://youtu.be/s5WmJk2sYOQ

To move around, bacteria used by Professor Martel’s team rely on two natural systems; a kind of compass created by the synthesis of a chain of magnetic nanoparticles allows them to move in the direction of a magnetic field, while a sensor measuring oxygen concentration enables them to reach and remain in the tumour active regions. By harnessing these two transportation systems and by exposing the bacteria to a computer-controlled magnetic field, researchers showed that these bacteria could perfectly replicate artificial nanorobots of the future designed for this kind of task.

“These results represent a novel therapeutic avenue for patients with hard-to-treat cancers, once the approach has been validated in human trials,” says co-author Nicole Beauchemin, a professor of Biochemistry, Medicine and Oncology at McGill and researcher at the Rosalind and Morris Goodman Cancer Research Centre.

An interview with Professor Martel with RT America to explain how the nanorobots are better at targeting cancer cells than current cancer treatments.

This work was supported by many research centers and consortiums in Canada such as the Consortium québécois sur la découverte du médicament (Québec consortium for drug discovery – CQDM), the Canada Research Chairs, the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Research Chair in Nanorobotics of Polytechnique Montréal.

To overcome some limitations of the previous approach, professor Martel has been leading a new research that uses the Particle Swarm Optimization (PSO) algorithm to increase the number of dimensions in the search space and to optimize targeting cancer cells in blood. This research took part at 2016 IEEE/RSJ International Conference on Intelligent Robots and Systemsrecently on October.

Besides replacing the toxic chemotherapy that has plenty of harmful side effects on the entire human body, this research will not only open doors for new inventions and applications, but it also will pave the way for inventing new medical, imaging and diagnostic agents.

You can find more details, videos and photos in this media kit from Université de Montréal. You can also check this TEDx talk by Professor Martel about using nanotechnology in healing cancer.

Source: NANOBOTS FIGHT CANCEROUS CELLS

Quick Solutions to Questions related to Nanorobotic Cancer Treatment:

  • How do nanorobotic agents navigate through the bloodstream?
    Bacteria use a chain of magnetic nanoparticles to move toward a magnetic field and an oxygen sensor to reach active tumor regions.
  • Can these nanorobots target hypoxic zones inside tumors?
    Yes, they autonomously detect oxygen-depleted areas known as hypoxic zones and deliver drugs directly to them.
  • What is the primary advantage over traditional chemotherapy?
    This approach avoids harmful side effects on the entire human body by targeting only cancerous cells locally.
  • Does this technology work without external control?
    The bacteria are self-propelled but require exposure to a computer-controlled magnetic field for direction.
  • What specific type of bacteria is used in this research?
    The study utilized more than 100 million flagellated bacteria that are naturally self-propelled.
  • Where was this research published?
    The results were published in the prestigious journal Nature Nanotechnology.
  • Has this method been tested on humans yet?
    No, the approach still needs validation in human trials before it can be used for patients.
  • What algorithm helps optimize targeting in blood flow?
    The Particle Swarm Optimization algorithm is used to increase dimensions in the search space for better targeting.

About The Author

Ibrar Ayyub

I am an experienced technical writer holding a Master's degree in computer science from BZU Multan, Pakistan University. With a background spanning various industries, particularly in home automation and engineering, I have honed my skills in crafting clear and concise content. Proficient in leveraging infographics and diagrams, I strive to simplify complex concepts for readers. My strength lies in thorough research and presenting information in a structured and logical format.

Follow Us:
LinkedinTwitter